BYSL |
bystin like |
- Major pathway of rRNA processing in the nucleolus and cytosol
|
|
|
CALM1 |
calmodulin 1 |
- CaMK IV-mediated phosphorylation of CREB
- CaMK IV-mediated phosphorylation of CREB
- Calmodulin induced events
- Cam-PDE 1 activation
- CaM pathway
- Platelet degranulation
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
- PKA activation
- DARPP-32 events
- Synthesis of IP3 and IP4 in the cytosol
- Calcineurin activates NFAT
- Calcineurin activates NFAT
- eNOS activation
- Transcriptional activation of mitochondrial biogenesis
- Inactivation, recovery and regulation of the phototransduction cascade
- Inactivation, recovery and regulation of the phototransduction cascade
- Stimuli-sensing channels
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- Ca2+ pathway
- Reduction of cytosolic Ca++ levels
- Sodium/Calcium exchangers
- Unblocking of NMDA receptors, glutamate binding and activation
- CREB1 phosphorylation through the activation of Adenylate Cyclase
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- Ras activation upon Ca2+ influx through NMDA receptor
- Smooth Muscle Contraction
- Smooth Muscle Contraction
- Activation of Ca-permeable Kainate Receptor
- Uptake and function of anthrax toxins
- VEGFR2 mediated vascular permeability
- VEGFR2 mediated cell proliferation
- Phase 0 - rapid depolarisation
- Ion homeostasis
- CLEC7A (Dectin-1) induces NFAT activation
- CLEC7A (Dectin-1) induces NFAT activation
- RHO GTPases activate IQGAPs
- RHO GTPases activate PAKs
- RHO GTPases activate PAKs
- RAF activation
- RAF/MAP kinase cascade
- Signaling by moderate kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Glycogen breakdown (glycogenolysis)
- Glycogen breakdown (glycogenolysis)
- Protein methylation
- Extra-nuclear estrogen signaling
- Loss of phosphorylation of MECP2 at T308
- Regulation of MECP2 expression and activity
- Ion transport by P-type ATPases
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Activation of RAC1 downstream of NMDARs
- Activation of RAC1 downstream of NMDARs
- Activation of AMPK downstream of NMDARs
- Long-term potentiation
- Long-term potentiation
- RAS processing
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated IL10 synthesis
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Chlorpromazine
- Cinchocaine
- Nicardipine
- Fluphenazine
- Isoflurane
- Trifluoperazine
- Loperamide
- Perphenazine
- Phenoxybenzamine
- Felodipine
- Melatonin
- Promethazine
- Pimozide
- Nifedipine
- Bepridil
- Calcium
- Aprindine
- Deacetoxyvinzolidine
- tert-butanol
- Trimethyllysine
- N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
- Prenylamine
- Flunarizine
- (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
- Myristic acid
- Calcium citrate
- Calcium citrate
- Calcium citrate
- Calcium Phosphate
- Calcium Phosphate
- Calcium Phosphate
- Calcium levulinate
- Calcium phosphate dihydrate
- Calcium phosphate dihydrate
- Calcium phosphate dihydrate
|
|
COPB1 |
COPI coat complex subunit beta 1 |
- Neutrophil degranulation
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
|
|
|
COPB2 |
COPI coat complex subunit beta 2 |
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
|
|
|
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
- Non-integrin membrane-ECM interactions
|
|
|
EGFR |
epidermal growth factor receptor |
- Signaling by ERBB2
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Signaling by ERBB4
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB2 signaling
- PLCG1 events in ERBB2 signaling
- PIP3 activates AKT signaling
- Signaling by EGFR
- GRB2 events in EGFR signaling
- GAB1 signalosome
- SHC1 events in EGFR signaling
- EGFR downregulation
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- EGFR interacts with phospholipase C-gamma
- EGFR Transactivation by Gastrin
- Constitutive Signaling by Aberrant PI3K in Cancer
- Signal transduction by L1
- Constitutive Signaling by EGFRvIII
- Inhibition of Signaling by Overexpressed EGFR
- RAF/MAP kinase cascade
- ERBB2 Regulates Cell Motility
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- ERBB2 Activates PTK6 Signaling
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- PTK6 promotes HIF1A stabilization
- Downregulation of ERBB2 signaling
- TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
- Extra-nuclear estrogen signaling
- NOTCH3 Activation and Transmission of Signal to the Nucleus
- HCMV Early Events
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 ECD mutants
- Signaling by ERBB2 TMD/JMD mutants
|
- Cetuximab
- Lidocaine
- Gefitinib
- Erlotinib
- Lapatinib
- Panitumumab
- Alvocidib
- IGN311
- Matuzumab
- Vandetanib
- Rindopepimut
- Canertinib
- Pelitinib
- Varlitinib
- AV-412
- S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
- PD-168393
- Afatinib
- Osimertinib
- Necitumumab
- Foreskin keratinocyte (neonatal)
- Depatuxizumab mafodotin
- Icotinib
- Neratinib
- Dacomitinib
- Fostamatinib
- Zalutumumab
- Brigatinib
- Olmutinib
- Zanubrutinib
- Abivertinib
|
|
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
|
|
|
GABBR1 |
gamma-aminobutyric acid type B receptor subunit 1 |
- Activation of G protein gated Potassium channels
- G alpha (i) signalling events
- Class C/3 (Metabotropic glutamate/pheromone receptors)
- GABA B receptor activation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
- Baclofen
- Progabide
- Taurine
- gamma-Aminobutyric acid
- SGS-742
- Tezampanel
- Arbaclofen
- Arbaclofen Placarbil
|
|
GNAI1 |
G protein subunit alpha i1 |
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- ADP signalling through P2Y purinoceptor 12
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Regulation of insulin secretion
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
|
- Guanosine-5'-Diphosphate
- Tetrafluoroaluminate Ion
|
|
GNAI2 |
G protein subunit alpha i2 |
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- ADP signalling through P2Y purinoceptor 12
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Regulation of insulin secretion
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
|
|
|
GNAO1 |
G protein subunit alpha o1 |
- Ca2+ pathway
- Ca2+ pathway
|
|
|
GNAQ |
G protein subunit alpha q |
- PLC beta mediated events
- PLC beta mediated events
- G-protein activation
- Acetylcholine regulates insulin secretion
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
- G alpha (q) signalling events
- ADP signalling through P2Y purinoceptor 1
- ADP signalling through P2Y purinoceptor 1
- Thromboxane signalling through TP receptor
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Thrombin signalling through proteinase activated receptors (PARs)
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
|
|
|
KRIT1 |
KRIT1 ankyrin repeat containing |
|
|
|
MPZ |
myelin protein zero |
- EGR2 and SOX10-mediated initiation of Schwann cell myelination
|
|
|
OSMR |
oncostatin M receptor |
- IL-6-type cytokine receptor ligand interactions
|
|
|
PFDN2 |
prefoldin subunit 2 |
- Prefoldin mediated transfer of substrate to CCT/TriC
|
|
|
PLCB1 |
phospholipase C beta 1 |
- PLC beta mediated events
- PLC beta mediated events
- Synthesis of IP3 and IP4 in the cytosol
- Acetylcholine regulates insulin secretion
- Acetylcholine regulates insulin secretion
- Ca2+ pathway
- G alpha (q) signalling events
- G alpha (q) signalling events
- G beta:gamma signalling through PLC beta
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Presynaptic function of Kainate receptors
|
|
|
PTAFR |
platelet activating factor receptor |
- Class A/1 (Rhodopsin-like receptors)
- G alpha (q) signalling events
- Interleukin-10 signaling
- Neutrophil degranulation
- Interferon gamma signaling
|
- Platelet Activating Factor
- Etizolam
- Rupatadine
|
|
RRM1 |
ribonucleotide reductase catalytic subunit M1 |
- Interconversion of nucleotide di- and triphosphates
|
- Cladribine
- Gemcitabine
- Clofarabine
- Hydroxyurea
- Fludarabine
- Imexon
- Gallium maltolate
- Tezacitabine
|
|
SDHC |
succinate dehydrogenase complex subunit C |
- Respiratory electron transport
- Citric acid cycle (TCA cycle)
|
- 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
- Ubiquinone Q1
|
|
UAP1 |
UDP-N-acetylglucosamine pyrophosphorylase 1 |
- Synthesis of UDP-N-acetyl-glucosamine
|
- Uridine-Diphosphate-N-Acetylgalactosamine
- Uridine-Diphosphate-N-Acetylglucosamine
|
|